Ignite Creation Date:
2024-05-06 @ 4:19 PM
Last Modification Date:
2024-10-26 @ 2:07 PM
Study NCT ID:
NCT04941885
Status:
RECRUITING
Last Update Posted:
2021-07-02
First Post:
2021-06-25
Brief Title:
Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2HR Breast Cancer
Sponsor:
Organization:
Sun Yat-sen University